Fisher & Paykel Healthcare Corporation Limited

Symbol: FPH.AX

ASX

23.66

AUD

Market price today

  • 61.8116

    P/E Ratio

  • 3.7087

    PEG Ratio

  • 13.82B

    MRK Cap

  • 0.01%

    DIV Yield

Fisher & Paykel Healthcare Corporation Limited (FPH-AX) Financial Statements

On the chart you can see the default numbers in dynamics for Fisher & Paykel Healthcare Corporation Limited (FPH.AX). Companys revenue shows the average of NaN M which is NaN % gowth. The average gross profit for the whole period is NaN M which is NaN %. The average gross profit ratio is NaN %. The net income growth for the company last year performance is NaN % which equals NaN % % on average for the whole company history.,

Balance Sheet

Diving into the fiscal trajectory of Fisher & Paykel Healthcare Corporation Limited, we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to . A look back at the past year reveals a total asset change of NaN. Shareholder value, as depicted by the total shareholder equity, is valued at NaN in the reporting currency. The year over year change in this aspect is NaN%.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001

balance-sheet.row.cash-and-short-term-investments

0113.3268.5347.2
140.3
135.1
142.1
75.5
28.5
13.6
10.4
7.7
6.3
6.1
6.9
5.5
5.3
7.7
28.6
37.1
47.6
48.3
73.3
102.2

balance-sheet.row.short-term-investments

00.5185.3257.7
75.3
88.8
112.1
19.4
11.5
23.8
33.1
28.4
21
14.9
21.4
6.3
2.9
0
12
14
17
35
0
0

balance-sheet.row.net-receivables

0237.9169.2210.5
216.3
152.9
138.9
120.7
120.3
107.4
93.4
81.6
77.1
79.6
71.4
81
60.3
58.5
55.4
54.6
49.1
59
41.8
34.1

balance-sheet.row.inventory

0342.4332.4248.8
141.9
130.7
117.9
123.7
109.2
96.1
94.5
89.1
84.4
80.1
71.8
69.9
50.8
46.7
36.2
30.9
24.1
21.9
19.2
18.3

balance-sheet.row.other-current-assets

031.152.239.4
4
18.4
0
1.9
1.7
1.8
1.3
1.1
0.4
0.3
1.8
7.2
8.6
5.3
4.5
0.5
0.3
4.6
6.3
8.6

balance-sheet.row.total-current-assets

0724.6822.4846
502.4
437.1
399
319.9
257.9
243.3
235
215.2
195
186.5
180.1
172.7
129.6
118.2
125.3
127.7
122.5
133.8
140.6
163.1

balance-sheet.row.property-plant-equipment-net

01074.7887.2811.1
712.2
577.4
448
389.6
351.6
367.4
349.8
346.7
311.6
254.3
233.3
204.6
186.5
141.9
128.3
82.9
71.5
71.4
64.9
58.9

balance-sheet.row.goodwill

0000
0
0
0
0
0
1.4
1.4
1.4
1
1
1
1
1
0.6
1
1.4
1.8
2.2
0
3

balance-sheet.row.intangible-assets

080.180.473.6
71.6
59
47.4
40.8
32.3
21
9
7.2
5.4
5.4
4.9
4.5
4.3
2.2
2.3
2.4
4
3.9
2.6
0

balance-sheet.row.goodwill-and-intangible-assets

080.180.473.6
71.6
59
47.4
40.8
32.3
22.4
10.4
8.6
6.4
5.4
4.9
4.5
4.3
2.9
3.3
3.8
4
3.9
2.6
3

balance-sheet.row.long-term-investments

093.584.2102.6
15.9
47.6
37.1
24.4
23.5
13.1
17.2
27.9
37.4
44.9
34.2
11
1.5
0
0
2.8
11.4
0
-3.1
0

balance-sheet.row.tax-assets

090.477.474.8
87.9
37.3
32.6
30.1
26.8
19.9
14.7
11.6
9.7
8.8
11
16.8
8.7
10.3
10.3
13.2
13.7
7.8
3.1
0

balance-sheet.row.other-non-current-assets

0000
0
0
0
0
0
3.6
3.3
8.6
11.9
17.7
11.6
4.2
1.1
1.4
0.3
0
0.9
11.8
7.3
11.7

balance-sheet.row.total-non-current-assets

01338.71129.21062
887.6
721.4
565.1
484.9
434.2
426.5
395.4
403.4
377
331.1
295
241.1
202.1
156.5
142.1
102.7
101.7
95
74.8
73.5

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

02063.41951.61908
1390
1158.5
964.1
804.7
692.1
669.8
630.3
618.6
572.1
517.6
475.1
413.7
331.7
274.7
267.5
230.3
224.2
228.8
215.3
236.7

balance-sheet.row.account-payables

040.249.852.1
67.1
52.9
30.8
26.9
33.4
27.7
23.2
21.1
22.5
21.1
22.8
23.7
14.7
15.9
19.2
15.1
10.8
8.7
8.4
8.5

balance-sheet.row.short-term-debt

019.915.724.5
89.3
16.6
28.1
19.3
14.7
14.2
45.8
17.1
80.2
17.1
24.5
23.4
65
40.8
23.8
8.1
6.3
3.1
7.5
8.6

balance-sheet.row.tax-payables

06.229.5137.6
34.3
23.4
20.7
13.5
17.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

07458.457.7
21.3
66.2
49.4
36.6
42.3
51.3
63.6
117.4
34.5
81.9
59.6
97.5
21.1
0
0
0
1.9
0
1.5
1.7

Deferred Revenue Non Current

042.500
0
0
0
0
0
0.3
0.7
2.9
3.1
3
2.1
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

0204.9186.4178.9
133.4
84.1
88.2
73.7
69.6
7.5
4.7
24.5
21.6
3.9
4.1
10
2.8
11.4
8.7
7.3
10.2
20.1
11.2
4.8

balance-sheet.row.total-non-current-liabilities

0151114.3116.4
122.6
104.7
80.2
65
68.2
81.5
95.4
155.3
73.3
120.1
84.1
115.6
25.6
1
1.1
0.9
2.5
1.2
1.7
21.9

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

042.522.526.7
21.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

0422.2395.8509.5
446.7
281.8
248
198.5
203.2
198.6
224.2
246.4
223.9
204.3
181.9
209.4
136
81.2
63.5
38.3
32.9
35.9
43.5
84.6

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

0287.3246.7231.1
221.8
212.2
189.4
168.1
149.5
145.9
120.4
91.3
63.3
38.7
13
4.1
3.6
193.5
204
192
170.6
172.7
171.9
152.1

balance-sheet.row.retained-earnings

01123.61094.1946.4
664.8
527.3
439.5
358.3
295.9
266.8
224.5
194.9
184
184.7
196.1
187.7
188.7
0
0
0
20.6
20.1
171.9
0

balance-sheet.row.accumulated-other-comprehensive-income-loss

0233.2219.8223.1
60.2
139
90
81.3
45.6
58.5
61.2
86
100.8
89.9
84.1
12.5
3.3
-53.9
-0.2
-3.6
-4
-2
-17.4
0

balance-sheet.row.other-total-stockholders-equity

0-3.1-4.7-2
-3.5
-1.7
-2.8
-1.5
-2.2
0
0
0
0
0
0
0
0
53.9
0.2
3.6
4
2
-154.5
0

balance-sheet.row.total-stockholders-equity

01641.11555.91398.5
943.2
876.8
716.1
606.3
488.9
471.2
406.1
372.2
348.2
313.3
293.2
204.3
195.7
193.5
204
192
191.2
192.8
171.9
152.1

balance-sheet.row.total-liabilities-and-stockholders-equity

02063.41951.61908
1390
1158.5
964.1
804.7
692.1
669.8
630.3
618.6
572.1
517.6
475.1
413.7
331.7
274.7
267.5
230.3
224.2
228.8
215.3
236.7

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

01641.11555.91398.5
943.2
876.8
716.1
606.3
488.9
471.2
406.1
372.2
348.2
313.3
293.2
204.3
195.7
193.5
204
192
191.2
192.8
171.9
152.1

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

093.5269.5360.4
91.1
136.4
149.2
43.8
35
36.9
50.4
56.2
58.5
59.8
55.7
17.3
4.3
0
12
14
17
35
-3.1
0

balance-sheet.row.total-debt

0136.596.6108.9
131.9
82.9
77.5
55.9
57
65.5
109.4
134.5
114.7
99
84.1
121
86.1
40.8
23.8
8.1
8.2
3.1
9
10.3

balance-sheet.row.net-debt

023.213.319.4
66.9
36.6
47.5
-0.2
40.1
51.9
98.9
126.8
108.5
92.9
77.2
115.5
80.9
33.1
7.3
-15
-22.4
-10.2
-64.3
-91.9

Cash Flow Statement

The financial landscape of Fisher & Paykel Healthcare Corporation Limited has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of NaN. The company recently extended its share capital by issuing NaN, marking a difference of NaN compared to the previous year. The company's investing activities resulted in net cash usage, amounting to NaN in the reporting currency. This is a shift of NaN from the previous year. In the same period, the company recorded NaN, NaN, and NaN, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of NaN, with a year over year difference of NaN. Furthermore, the company allocated NaN for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as NaN, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001

cash-flows.row.net-income

0234.3349.1482
278.3
200.9
178.9
155
129.5
0
97.1
77.1
64.1
52.5
71.6
62.2
35.3
57.6
70
61.4
54.7
72.9
48.1
9.7

cash-flows.row.depreciation-and-amortization

092.788.978.2
59.1
40
41.9
35.8
31.8
0
28
21.2
17.8
16.2
13.5
14.3
14.1
13.3
9.5
8.1
7.3
8.4
6.1
5.8

cash-flows.row.deferred-income-tax

04.5-6.3-54.3
-23.2
-3.2
0.5
-1.8
-16.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0-250.1-216.3-214.7
-145.6
-85
-84.1
-78.7
-90.9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0-64.8-38.4-58.4
-27.4
-1.2
6.5
-11.3
-16.8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.account-receivables

0-40.548.6-4.7
-62.8
-11.3
-15.4
3.9
-23.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0-6.5-81.8-114.1
-10.1
-10.3
9
-12.9
-22.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.account-payables

0-17.8-5.360.4
45.4
16.7
6.2
1.8
18.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0000
0
3.6
6.7
-4.2
10.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-non-cash-items

0206.4123.4342.2
170.2
91.7
89.3
-0.3
2.6
0
-27.4
-28.9
-7.9
-16.5
21.4
-25.2
-11
-70.9
2.9
-3.2
-9.5
-81.4
1.9
-15.5

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-197.8-157.3-169.8
-165.3
-128
-92.8
-57.7
-59.4
-53.6
-31.9
-62
-67.5
-43.3
-48.3
-22.4
-13.5
-28.7
-53.6
-16.8
-9.5
-16.5
-13.2
0

cash-flows.row.acquisitions-net

0000
0
0.1
0.2
0.1
0
0
0
0
0
0
0
0
0
1.1
1.1
0.9
0
0
0
0

cash-flows.row.purchases-of-investments

000-186.3
0
0
-94
0
0
0
0
0
0
0
0
0
0
-7
-22
-55.3
-80.8
-149.1
0
0

cash-flows.row.sales-maturities-of-investments

0187.274.40
14.5
7.2
0
0
0
0
0
0
0
0
0
0
0
18.8
23.9
58.3
98.5
114.5
299.3
0

cash-flows.row.other-investing-activites

0000
0
0
0
0
0
-14.3
0
0.1
0
0.1
0.1
0
0
-1
-1.1
-1
0
0.1
-5.6
0

cash-flows.row.net-cash-used-for-investing-activites

0-10.6-82.9-356.1
-150.8
-120.7
-186.7
-57.6
-59.3
-53.6
-31.9
-62
-67.5
-43.2
-48.2
-22.4
-13.5
-16.7
-51.7
-13.8
8.2
-51
280.5
0

cash-flows.row.debt-repayment

0-9.4-0.1-45.3
-5
-0.6
-20.3
0
-7.3
-50.2
-30.8
-68.6
-16.8
-27.8
-47.2
-8.6
-12.5
0
-68.5
0
0
-15.7
-14.8
0

cash-flows.row.common-stock-issued

02.833.2
2.2
0.3
0.8
0.7
0.8
1.6
27.1
26.1
23.8
23.3
7
0.2
1.1
0.9
1
1.2
2.3
3.8
30.5
0

cash-flows.row.common-stock-repurchased

00.9146.1
0.3
0
0
0
0
5
8.8
86.6
38.2
35.1
17.6
37
-12.3
0
-5.1
-8
-2.2
0
-212
0

cash-flows.row.dividends-paid

0-183.2-208.3-166.7
-141.8
-110
-96.4
-81.9
-61.5
-47.9
-72.1
-71.1
-70.2
-68.7
-68.1
-66.3
-68
-68.5
-62
-58.7
-56.1
-52.8
-79
0

cash-flows.row.other-financing-activites

04.3-14-10.2
-9.7
1.7
41.5
0.7
0.6
5.5
0.3
0.6
0.6
0.6
0.5
0.6
55.8
19.6
84
0
0
10.7
-2.4
0

cash-flows.row.net-cash-used-provided-by-financing-activities

0-184.5-218.4-172.9
-154
-108.6
-74.4
-80.4
-67.4
-91
-66.7
-26.5
-24.6
-37.5
-90.3
-37.1
-35.8
-48
-50.7
-65.5
-56
-54.1
-277.6
0

cash-flows.row.effect-of-forex-changes-on-cash

02.40.2-1
-1.2
0.6
1.9
0.2
-1.2
1
0.2
1
0.7
-0.2
0.1
0.5
-0.6
-0.4
0.1
-0.2
-0.4
-0.7
-0.3
0

cash-flows.row.net-change-in-cash

030-6.224.5
18.7
16.3
-26.1
39.2
17.4
3.2
5.7
-1
2.6
-9.9
-0.9
3.1
-5.6
-8.8
-5.8
-7.4
12
-59.8
70.3
0

cash-flows.row.cash-at-end-of-period

0113.383.389.5
65
46.3
30
56.1
16.9
-0.5
-3.8
-9.4
-8.4
-11
-1.1
-0.2
-3.3
2.3
11
16.8
24.3
12.2
72
0

cash-flows.row.cash-at-beginning-of-period

083.389.565
46.3
30
56.1
16.9
-0.5
-3.8
-9.4
-8.4
-11
-1.1
-0.2
-3.3
2.3
11
16.8
24.3
12.2
72
1.7
0

cash-flows.row.operating-cash-flow

0222.9300.4575
311.3
243.2
233.1
177.4
130.5
144
97.6
69.3
74
52.2
106.5
51.3
38.4
56.3
82.4
66.4
52.5
46
56.1
0

cash-flows.row.capital-expenditure

0-197.8-157.3-169.8
-165.3
-128
-92.8
-57.7
-59.4
-53.6
-31.9
-62
-67.5
-43.3
-48.3
-22.4
-13.5
-28.7
-53.6
-16.8
-9.5
-16.5
-13.2
0

cash-flows.row.free-cash-flow

025.2143.1405.1
146
115.2
140.2
119.7
71.1
90.4
65.8
7.3
6.5
8.9
58.3
28.9
24.9
27.6
28.8
49.6
42.9
29.5
42.9
0

Income Statement Row

Fisher & Paykel Healthcare Corporation Limited's revenue saw a change of NaN% compared with the previous period. The gross profit of FPH.AX is reported to be NaN. The company's operating expenses are NaN, showing a change of NaN% from the last year. The expenses for depreciation and amortization are NaN, which is a NaN% change from the last accounting period. Operating expenses are reported to be NaN, which shows a NaN% year-over-year change. Selling and marketing expenses are NaN, which is a NaN% change compared to the previous year. The EBITDA based on the recent numbers is NaN, representing a NaN% year-over-year growth. The operating income is NaN, which shows a NaN% change when compared to the previous year. The change in the net income is NaN%. The net income for the last year was NaN.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001

income-statement-row.row.total-revenue

01486.91521.31791.4
1233.4
1029.3
907.1
796.8
738.7
644
568.6
507.3
466.7
467.7
474.8
485.5
346
349.2
289.5
241.1
214.9
208.4
213.3
192.8

income-statement-row.row.cost-of-revenue

0601.6582.6667.2
414.5
340.4
310.7
278.6
265.2
261.4
258
248.4
241.7
228.4
231.9
212.1
177.8
149.1
121.4
67.2
62.6
67.6
65.8
0

income-statement-row.row.gross-profit

0885.3938.71124.2
819
688.9
596.4
518.2
473.5
382.6
310.6
258.8
225.1
239.3
242.8
273.4
168.2
200.1
168.2
173.9
152.3
140.9
147.4
192.8

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0-7.640.232.4
-16.8
3.3
21.4
31.3
2
33.3
59.4
52.8
52.4
39.6
32.8
-23.8
11.9
7.2
34.9
12
10.7
76
-111.6
-50

income-statement-row.row.operating-expenses

0567.4506.8490.4
442.2
388.6
348
325.6
284.8
277.5
255.5
223.9
207.2
203.2
190.3
164.5
138.2
131
108.6
92.4
81.6
75.4
6.1
63.3

income-statement-row.row.cost-and-expenses

01168.91089.41157.6
856.7
729.1
658.7
604.2
550
538.9
513.5
472.3
448.8
431.6
422.2
376.6
315.3
280.1
341.8
159.7
206.8
210.6
139.1
63.3

income-statement-row.row.interest-income

02.42.41.4
2.1
3.2
1.5
0.4
0.1
0.1
0.1
0.2
0.3
0.6
0.7
1.3
0.7
0.8
1.2
1.6
2.4
3.5
1.3
0.2

income-statement-row.row.interest-expense

06.34.54.6
3.8
2.4
3.5
3.5
8.2
11.5
7.8
4.9
0.8
5.5
-3.3
18.6
4.5
2.9
0.8
0.3
0.4
0.5
1.6
2.2

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-1135.126.6
-17.9
-25.4
-1.2
21.3
-12
33.3
59.4
52.8
52.4
39.6
32.8
-23.8
11.9
7.2
34.9
10.1
10.3
45.8
-112
-50

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0-7.640.232.4
-16.8
3.3
21.4
31.3
2
33.3
59.4
52.8
52.4
39.6
32.8
-23.8
11.9
7.2
34.9
12
10.7
76
-111.6
-50

income-statement-row.row.total-operating-expenses

0-1135.126.6
-17.9
-25.4
-1.2
21.3
-12
33.3
59.4
52.8
52.4
39.6
32.8
-23.8
11.9
7.2
34.9
10.1
10.3
45.8
-112
-50

income-statement-row.row.interest-expense

06.34.54.6
3.8
2.4
3.5
3.5
8.2
11.5
7.8
4.9
0.8
5.5
-3.3
18.6
4.5
2.9
0.8
0.3
0.4
0.5
1.6
2.2

income-statement-row.row.depreciation-and-amortization

092.788.978.2
59.1
40
41.9
35.8
31.8
0
28
21.2
17.8
16.2
13.5
14.3
14.1
13.3
9.5
8.1
7.3
8.4
6.1
5.8

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0318431.9633.8
376.8
300.2
248.4
192.6
188.7
201.9
55.1
34.9
17.9
36.1
52.6
108.9
30.7
69.1
69.2
81.5
70.6
65.4
75.2
129.6

income-statement-row.row.income-before-tax

0307467660.4
358.9
274.8
247.2
213.9
176.8
158.8
136.7
109.4
92.3
92.8
106.8
85
54.3
87.5
104.4
91.6
80.9
111.2
93.9
16.8

income-statement-row.row.income-tax-expense

072.7117.9178.4
80.6
73.9
68.3
58.9
47.3
45.6
39.6
32.3
28.2
40.3
35.2
22.8
19
29.9
34.5
91.6
80.9
111.2
93.9
16.8

income-statement-row.row.net-income

0250.3376.9524.2
287.3
209.2
190.2
169.2
143.4
113.2
97.1
77.1
64.1
52.5
71.6
62.2
35.3
57.6
70
61.4
54.7
72.9
48.1
9.7

Frequently Asked Question

What is Fisher & Paykel Healthcare Corporation Limited (FPH.AX) total assets?

Fisher & Paykel Healthcare Corporation Limited (FPH.AX) total assets is 2063359237.000.

What is enterprise annual revenue?

The annual revenue is N/A.

What is firm profit margin?

Firm profit margin is 0.601.

What is company free cash flow?

The free cash flow is 0.051.

What is enterprise net profit margin?

The net profit margin is 0.153.

What is firm total revenue?

The total revenue is 0.219.

What is Fisher & Paykel Healthcare Corporation Limited (FPH.AX) net profit (net income)?

The net profit (net income) is 250300000.000.

What is firm total debt?

The total debt is 136465310.000.

What is operating expences number?

The operating expences are 567388691.000.

What is company cash figure?

Enretprise cash is 0.000.